Smart-4-Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart-4-Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.
The project started on
the 1st January 2017 and will last four years.
CONSORTIUM
NEWS
-
2.11.2020Small drugs – Big considerations: How New Deal researchers are overcoming the challenges of scaling-up a potential IBD nanomedicine
A great chef could create an outstanding dish that revolutionizes cuisine – every time t...
-
23.10.2020Nanomedicine comes of age: European researchers take nanotech-based therapies from the lab to the clinic
There are already more than 50 nanomedicine formulations in the market and over 400 curren...
-
19.10.202014th Mediterranean Congress of Chemical Engineering
It is our pleasure to inform you that (virtual) oral communication under the tittle “Sca...